The FDA Advisory Committee will meet on June 7, 2022, 8:30 AM – 5:00 PM ET to discuss the Novavax Covid-19 vaccine EUA application.
The vaccine is a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2rS) with Matrix-M1 Adjuvant.
● About Me
I’m Jim Amos MD, the creator and author behind this blog. I’m a retired psychiatrist who enjoys playing cribbage, juggling and still loves life-long learning. Watch out; I’m gonna pull your leg! Check out my YouTube site
Contact Form below:
Go Retire Psychiatrist 
Leave a comment